Emertel
Kim Giliam is an accomplished professional with extensive experience in the biotechnology and medical industries. Currently serving as the Managing Director and Founder of Centromere since March 2020, Kim also holds the position of Chief Scientific Officer at LUMINAIR, where expertise in industry development, biotechnology, and renewable portfolios is provided. Additional roles include Advisor at Emertel and Approved Advisor at the Advisory Board Centre. Previous experience includes leadership positions at Genea Biomedx, Genea, and Cook Medical, where responsibilities spanned commercial direction and global business development in assisted reproductive technologies. Kim Giliam holds an MBA in Entrepreneurship and Leadership from Queensland University of Technology, a Cert IV in Project Management from the Australian College of Project Management, and a BSc (Hons) in Reproductive Biology/Physiology from Monash University.
This person is not in any teams
Emertel
Emertel partners with B2B and B2B2C platform scale-ups to help them scale up across the Indo-Pacific. Services span strategic advice to in market execution for product development, offer localisation, channel development and customer acquisition in Australia, New Zealand, Japan, South Korea, Singapore and India. Headquartered in Melbourne, Australia.